Key market opportunities include the adoption of automated sample preparation systems driven by the need for reproducibility and error reduction. High R&D investments by pharma companies for faster ...

YINZHOU DISTRICT, NINGBO CITY, ZHEJIANG, CHINA, January 21, 2026 /EINPresswire.com/ -- In the fast-evolving world of ...

Dental 3D Printing MarketThe dental 3D printing market is witnessing robust growth, with an anticipated compound annual growth rate (CAGR) of approximately 20% over the forecast period. This expansion ...

JIEZHUANG STREET, JINING HIGH-TECH ZONE, SHANDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- In recent years, the ...

The global structural adhesives market is projected to grow significantly, driven by demand for lightweight materials in ...

Securitize reported 841% revenue growth for nine months, advancing its merger with Cantor Equity Partners II.

Challenges and risks are rising fast, and the political unity and stability that underpinned the post-war era is unravelling. This will make any coordinated response significantly harder precisely ...

Oxford Lane Capital Corporation cut its monthly distribution 50% as NAV plunged and fees hurt returns. Click for this updated ...

Domain Money reports on key Q1 strategies for 2026 financial success, focusing on goal-setting, retirement contributions, and ...

Beat average interest rates with one of the top high-yield savings accounts ...

Biotech company Regeneron (NASDAQ:REGN) reported in Q4 CY2025, with sales up 2.5% year on year to $3.88 billion. Its non-GAAP profit of $11.44 per share was 6.9% above analysts’ consensus estimates.

Results Summary Change Change vs Dollars in millions (except per vs 4Q25 3Q25 3Q25 share data) 2025 2024 2024 6,501 7,548 -1,047 Earnings (U.S. GAAP) 28,844 33,680 -4,836 Earnings Excluding Identified ...